Zidovudine
The first HIV drug, still used to prevent mother-to-child transmission.
- Starts working
- Weeks
- Half-life
- About 1 hour (intracellular 7 hours)
- In use since
- —
- Pregnancy
- Generally considered safe
Overview
Zidovudine (AZT) is used in some combination regimens and during labour for babies at high HIV risk. It can cause anaemia and low white cells, so it is largely replaced by tenofovir-based regimens.
Conditions it's used for
How it works
Blocks HIV from copying itself.
Zidovudine belongs to the Nucleos(t)ide reverse transcriptase inhibitors. How Nucleos(t)ide reverse transcriptase inhibitors work: act as faulty building blocks that stop the virus copying its genetic material into DNA.
Uses
- HIV infection (with other drugs)
- Preventing mother-to-child HIV transmission
Available as: capsule, tablet, oral solution, iv infusion, combination tablets.
Typical dose
- Adults
- 300 mg twice a day.
- Children
- Weight-based dosing.
- Good to know
- Doses for infants are specific.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Nausea
- Headache
- Tiredness
- Anaemia
Serious — get medical help
Uncommon, but need prompt attention
- Severe anaemia
- Low white blood cells
- Muscle toxicity
- Lactic acidosis
Warnings
- Needs regular blood counts
- Avoid with stavudine
Who should avoid it
- Low haemoglobin or neutrophil count
- Taking stavudine
Interactions
- Ganciclovir, chemotherapy, co-trimoxazole — added bone marrow suppression
- Stavudine — antagonism; avoid
- Rifampicin — lowers levels
Using it safely
- Alcohol
- Best to limit. Alcohol adds to liver and bone marrow strain.
- Food and drink
- With or without food; take with food if nauseous.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Do not stop without advice.
- Driving
- Tiredness may affect alertness.
- Tests and checks
- Full blood count; Liver tests; Viral load
- If too much is taken
- Nausea, vomiting and bone marrow effects. Seek help.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Generally considered safe
Used for decades in pregnancy to reduce transmission.
Breastfeeding
Usually avoided
Not recommended where safe formula is available.
Special groups
- Kidney disease
- Reduce dose in severe impairment.
- Liver disease
- Reduce dose in liver disease.
- Older adults
- Check blood counts.
Brand names
- United States
- Retrovir
- United Kingdom
- Retrovir
- India
- Zidovir, Retrovir
- Australia
- Retrovir
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Zidovudine?
Yes — Zidovudine is prescription-only in most countries.
Can I take Zidovudine during pregnancy?
Generally considered safe. Used for decades in pregnancy to reduce transmission. Always check with a doctor or midwife.
How quickly does Zidovudine work?
Weeks.
Related medicines
Lamivudine
Backbone antiretroviral also active against hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsAbacavir
NRTI with a serious HLA-B*5701 hypersensitivity warning.
RxWHONucleos(t)ide reverse transcriptase inhibitorsTenofovir disoproxil
Backbone drug for HIV treatment, PrEP and hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitorsEfavirenz
NNRTI used in first-line HIV regimens, with vivid dreams as a common side effect.
RxWHONon-nucleoside reverse transcriptase inhibitorsEmtricitabine-tenofovir
Two-drug HIV backbone and daily HIV prevention pill (PrEP).
RxNucleos(t)ide reverse transcriptase inhibitorsEntecavir
First-line antiviral for chronic hepatitis B.
RxWHONucleos(t)ide reverse transcriptase inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — J05AF01
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.